US stocks were mixed on Thursday, with the Dow firmly lower and the S&P 500 and Nasdaq eking out fresh record highs, though ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...

In a report released on July 21, Stephen Tusa from J.P. Morgan maintained a Buy rating on 3M, with a price target of $175.00. The company’s shares closed yesterday at $151.20. Take advantage of ...